MetaCap

Accuray (ARAY) vs SiNtx Technologies (SINT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Accuray (ARAY) has outperformed SiNtx Technologies (SINT) over the past year, gaining 97.6% versus a loss of 65.7%. Over five years, ARAY leads with a -59.5% price change compared with -100.0% for SINT. SiNtx Technologies is the larger company by market cap ($8.3 million vs $6.2 million), about 1.3 times the size, while Accuray is growing revenue faster (-12.3% vs -64.7%).

Accuray converts more of its revenue into profit, with a net margin of -12.2% versus -1018.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ARAY+97.62%SINT-65.73%
+281%+87%-107%
Nov 21, 20251 yearNov 20, 2026
ARAY-61.79%SINT-99.99%
+5%-50%-105%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ARAY versus SINT key metrics
MetricARAYSINT
Share price$2.08$1.10
Market cap$6.22M$8.31M
1-day change-2.12%-8.74%
YTD return+153.05%-71.50%
1-year return+97.62%-65.73%
5-year return-59.47%-99.99%
EPS (TTM)$-5.60$-1.54
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$401.95M$1.02M
Revenue growth (YoY)-12.34%-64.74%
Net income (latest FY)$-49.19M$-10.36M
Gross margin27.73%45.28%
Operating margin-6.58%-1053.14%
Net margin-12.24%-1018.07%
52-week high$45.20$4.46
52-week low$2.05$1.09
Distance from 52-week high-95.41%-75.34%
Analyst consensusnonestrong_buy
Avg. price target upside—+740.91%
Average volume201.35K48.13K
Shares outstanding3.00M7.56M
Employees80932
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ARAY has outperformed SINT by 163.4 percentage points over the past year.
  • Accuray is more profitable, keeping -12.2 cents of every revenue dollar as net income versus -1018.1 cents for SiNtx Technologies.
  • Accuray grew revenue faster in its latest fiscal year (-12.34% vs -64.74%).

About Accuray

ARAY stock →

Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.

Health Care · Medical/Dental Instruments · 809 employees

About SiNtx Technologies

SINT stock →

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).

Health Care · Medical/Dental Instruments · 32 employees

ARAY vs SINT FAQ

Which is bigger, Accuray or SiNtx Technologies?

SiNtx Technologies (SINT) is larger, with a market capitalization of $8.31M compared with $6.22M for Accuray (ARAY).

Which stock has performed better over the past year, ARAY or SINT?

ARAY returned +97.62% over the past 12 months, compared with -65.73% for SINT (price return, excluding dividends). Past performance does not predict future results.

Are Accuray and SiNtx Technologies in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons